From: Factors influencing global antiretroviral procurement prices
听 | More than lowest direct manufactured costs | More than highest direct manufactured costs | ||||||
---|---|---|---|---|---|---|---|---|
听 | Odds ratio | p-value | Lower 95%CI | Upper 95%CI | Odds ratio | p-value | Lower 95% CI | Upper 95% CI |
HIV prevelence < 2% | 1 | 听 | 听 | 听 | 1 | 听 | 听 | 听 |
HIV Prevelence 2-5% | 0.75 | 0.174 | 0.50 | 1.13 | 1.17 | 0.389 | 0.81 | 1.70 |
HIV Prevalence >5% | 0.86 | 0.300 | 0.65 | 1.14 | 1.36 | 0.103 | 0.94 | 1.97 |
Low income | 1 | 听 | 听 | 听 | 1 | 听 | 听 | 听 |
Lower-middle income | 1.43 | 0.079 | 0.96 | 2.14 | 1.63 | 0.010 | 1.13 | 2.37 |
Upper-middle income | 4.05 | 0.000 | 2.23 | 7.34 | 2.02 | 0.003 | 1.27 | 3.23 |
PI* | 0.99 | 0.311 | 0.98 | 1.00 | 0.99 | 0.480 | 0.98 | 1.00 |
Volume 1 st tercile | 1 | 听 | 听 | 听 | 1 | 听 | 听 | 听 |
Volume 2 nd tercile | 0.76 | 0.211 | 0.50 | 1.17 | 1.28 | 0.060 | 0.99 | 1.65 |
Volume 3 th tercile | 0.56 | 0.016 | 0.35 | 0.90 | 0.69 | 0.055 | 0.48 | 1.01 |
Innovator | 4.01 | 0.003 | 1.60 | 10.45 | 6.10 | 0.000 | 3.09 | 12.05 |
CHAI** | 0.77 | 0.255 | 0.49 | 1.20 | 0.53 | 0.001 | 0.36 | 0.77 |
PEPFAR*** | 0.88 | 0.482 | 0.61 | 1.26 | 1.27 | 0.143 | 0.92 | 1.75 |
Pseudo R2 | 0.0994 | 听 | 听 | 听 | 0.1752 | 听 | 听 | 听 |
Number of obs | 9161 | 听 | 听 | 听 | 9161 | 听 | 听 | 听 |